1 |
Pastor A, Conn J, Macisaac RJ, Bonomo Y. Alcohol and illicit drug use in people with diabetes. The Lancet Diabetes & Endocrinology 2020;8:239-48. [DOI: 10.1016/s2213-8587(19)30410-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
|
2 |
DeYoung OA, Boehmer K, Hung D, McAdam-Marx C. A historical cohort study of glycemic control in patients with concurrent type 2 diabetes and substance use disorder treated in a primary care setting. Fam Pract 2021:cmab008. [PMID: 33738503 DOI: 10.1093/fampra/cmab008] [Reference Citation Analysis]
|
3 |
Kumar P, Srivastava S, Mishra PS, Mooss ETK. Prevalence of pre-diabetes/type 2 diabetes among adolescents (10-19 years) and its association with different measures of overweight/obesity in India: a gendered perspective. BMC Endocr Disord 2021;21:146. [PMID: 34233661 DOI: 10.1186/s12902-021-00802-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
4 |
Hendijani F, Hosseini FS. Interindividual variability in diabetic patients’ response to opium poppy: an overview of impressive factors. Personalized Medicine 2022;19:155-63. [DOI: 10.2217/pme-2021-0107] [Reference Citation Analysis]
|
5 |
Ojo O, Wang XH, Ojo OO, Ibe J. The Impact of Opium Abuse on Lipid Profile in Patients with Diabetes: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health 2019;16:E4795. [PMID: 31795366 DOI: 10.3390/ijerph16234795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
6 |
Piraiee E, Hassanipour S, Shojaie L, Vali M, Nikbakht H, Rezaei F, Ghaem H. Opium use and type 2 diabetes: a systematic review and meta-analysis. Journal of Substance Use. [DOI: 10.1080/14659891.2021.1967476] [Reference Citation Analysis]
|